First molecular test that selects immunotherapy for kidney cancer

(SingHealth) National Cancer Centre Singapore and Lucence Diagnostics Announce First Molecular Test that Selects Immunotherapy for Kidney Cancer. - Study was conducted on 36 kidney cancer patients using the CLEARScore test that identifies eight genes linked to immunotherapy. - Findings from this study will be presented at the 2019 ASCO Genitourinary Cancers Symposium in San Francisco.

https://www.eurekalert.org/pub_releases/2019-02/s-fmt021719.php

Source: EurekAlert! - Cancer - February 19, 2019 Category: Cancer & Oncology Source Type: news